Mads Nielsen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Polycystic Ovary Syndrome

Randomized Controlled Trial

Artificial Intelligence

Breast Cancer Risk

Top Venues

Journal of medical imaging (Bellingham, Wash.)

Radiology. Artificial intelligence

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas D Lauritzen, Martin Lillholm, Neda Esmailzadeh Bruun-Rasmussen, Mads Nielsen, Nico Karssemeijer, Ilse Vejborg
Early Indicators of the Impact of Using AI in Mammography Screening for Breast Cancer. Radiology 311 (3) (2024)
Mohammad Talal Elhakim, Sarah W Stougaard, Ole Graumann, Mads Nielsen, Oke Gerke, Lisbet B Larsen, Benjamin Schnack Brandt Rasmussen
AI-integrated Screening to Replace Double Reading of Mammograms: A Population-wide Accuracy and Feasibility Study. Radiology. Artificial intelligence (2024)
Andreas D Lauritzen, Martin Lillholm, Neda Esmailzadeh Bruun-Rasmussen, Mads Nielsen, Nico Karssemeijer, Ilse Vejborg
Early Indicators of the Impact of Using AI in Mammography Screening for Breast Cancer. Radiology 311 (3) (2024)
Andreas D Lauritzen, My Catarina von Euler-Chelpin, Elsebeth Lynge, Ilse Vejborg, Mads Nielsen, Nico Karssemeijer, Martin Lillholm
Robust cross-vendor mammographic texture models using augmentation-based domain adaptation for long-term breast cancer risk. Journal of medical imaging (Bellingham, Wash.) 10 (5) (2023)
Andreas D Lauritzen, My Catarina von Euler-Chelpin, Neda Esmailzadeh Bruun-Rasmussen, Ilse Vejborg, Mads Nielsen, Nico Karssemeijer, Martin Lillholm
Assessing Breast Cancer Risk by Combining AI for Lesion Detection and Mammographic Texture. Radiology 308 (2) (2023)
Andreas D Lauritzen, Alejandro Rodríguez-Ruiz, My Catarina von Euler-Chelpin, Neda Esmailzadeh Bruun-Rasmussen, Ilse Vejborg, Mads Nielsen, Nico Karssemeijer, Martin Lillholm
An Artificial Intelligence-based Mammography Screening Protocol for Breast Cancer: Outcome and Radiologist Workload. Radiology 304 (1) (2022)